Guangzhou Medical University, formerly known as Guangzhou Medical College, is a Chinese medical school located in Guangzhou.

During the past decade, Cancer Center of Guangzhou Medical University conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 2 clinical trials were completed, i.e. on average, 5.7% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 2 clinical trials were completed. i.e. 8.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Center of Guangzhou Medical University" #1 sponsor was "BeiGene" with 8 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Sun Yat-sen University" with 5 trials sponsored, "Affiliated Cancer Hospital & Institute of Guangzhou Medical University" with 2 trials sponsored and "Xynomic Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Center of Guangzhou Medical University" #1 collaborator was "Affiliated Cancer Hospital & Institute of Guangzhou Medical University" with 4 trials as a collaborator, "Wuzhou Red Cross Hospital" with 3 trials as a collaborator, "Yuebei People's Hospital" with 3 trials as a collaborator, "Zhongshan People's Hospital, Guangdong, China" with 3 trials as a collaborator and "Fifth Affiliated Hospital, Sun Yat-Sen University" with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Center of Guangzhou Medical University" are "Nasopharyngeal Carcinoma" (4 trials), "Non-Small Cell Lung Cancer" (4 trials), "Chemotherapy" (3 trials), "Non-small Cell Lung Cancer" (3 trials) and "Radiotherapy" (3 trials). Many other conditions were trialed in "Cancer Center of Guangzhou Medical University" in a lesser frequency.

Most popular intervention types in "Cancer Center of Guangzhou Medical University" are "Drug" (33 trials), "Radiation" (3 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tislelizumab" (7 trials), "Placebo" (5 trials), "Atezolizumab" (4 trials), "Carboplatin" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Center of Guangzhou Medical University" are 33 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Cancer Center of Guangzhou Medical University". undefined are not yet recruiting, 14 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cancer Center of Guangzhou Medical University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Center of Guangzhou Medical University, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".